Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate long-term safety of etanercept with or without other DMARDs in
children with polyarticular course or systemic juvenile rheumatoid arthritis (JRA) compared
to a cohort of subjects with polyarticular or systemic JRA receiving methotrexate with or
without other DMARDs.